✦ LIBER ✦

FOLFOX4 With Cetuximab vs. UFOX With Cetuximab as First-Line Therapy in Metastatic Colorectal Cancer: The Randomized Phase II FUTURE Study

✍ Scribed by Douillard, Jean-Yves; Zemelka, Tomasz; Fountzilas, George; Barone, Carlo; Schlichting, Michael; Heighway, Jim; Eggleton, S. Peter; Srimuninnimit, Vichien

Book ID: 122149476
Publisher: CIG Media Group, LP.
Year: 2014
Tongue: English
Weight: 454 KB
Volume: 13
Category: Article
ISSN: 1533-0028
DOI: 10.1016/j.clcc.2013.11.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3046 POSTER A randomized, open-label pha

3046 POSTER A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + Cetuximab versus FOLFIRI + Cetuximab as first-line therapy in patients with metastatic colorectal cancer

✍ T.E. Ciuleanu; W. Scheithauer; G. Kurteva; J. Ocvirk; I. Koza; D. Papamichael; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A Phase II Trial of FOLFOX6 and Cetuxima

A Phase II Trial of FOLFOX6 and Cetuximab in the First-line Treatment of Patients With Metastatic Colorectal Cancer

✍ Ralph V. Boccia; Thomas M. Cosgriff; David L. Headley; Suprith Badarinath; Shake 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 410 KB

Axitinib and/or bevacizumab with modifie

Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: A randomized phase 2 study

✍ Infante, Jeffrey R.; Reid, Tony R.; Cohn, Allen L.; Edenfield, William J.; Cesco 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

A phase II randomized study of cetuximab

A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma

✍ Andrew H. Ko, Hagop Youssoufian, Jayne Gurtler, Karel Dicke, Omar Kayaleh, Heinz 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 177 KB

Results of a Phase II Trial of Cetuximab

Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer

✍ Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

6079 Overall survival of patients with K

6079 Overall survival of patients with KRAS wild-type tumours treated with FOLFOX4± cetuximab as 1st-line treatment for metastatic colorectal cancer: The OPUS study

✍ Bokemeyer, C.; Bondarenko, I.; Hartmann, J.T.; DeBraud, F.; Schuch, G.; Zubel, A 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB